Skip to content

Orthotics and Running

A Randomised Control Trial to Compare Comfort, Rate of Injury and Speed While Running Using Prefabricated Orthotic Inserted Into Running Shoes vs Running With no Additional Orthotic Inside the Running Shoe

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04901442
Enrollment
106
Registered
2021-05-25
Start date
2021-07-23
Completion date
2022-12-31
Last updated
2022-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Occurence of Running Related Injuries, Running Comfort, Running Speed

Brief summary

To investigate whether a prefabricated Orthotic inserted into running shoes will increase comfort, decrease injury and improve speed during recreational running as compared to running shoes without the prefabricated Orthotic.

Detailed description

Running is the most accessible sport in the world. Data from the UK House of Commons has indicated that running has become the favourite exercise among adults 16 or older. However, as the sport grows, so too does the number of running-related injuries (RRIs). An Orthotic is a device that is placed inside the shoe and functions as a cushion to absorb the shock transmitted on contact with the ground; in addition, they also affect muscle activation that can benefit the user. However, in contemporaneous medical literature, there are mixed views and opinions on whether the use of Orthotics reduces running-related injuries. This is a randomised control trial that will be conducted over an 8-week period, during which participants will be asked to complete runs and provide data in the form of completed surveys. The primary objective of this study is to investigate whether a prefabricated Orthotic inserted into running shoes will increase comfort, decrease injury and improve speed during recreational running as compared to running shoes without the prefabricated Orthotic. The study population will include 106 participants who will be randomised into the study and control group. Participants in the study group will be provided with an Orthotic and will run with this in the participants normal running shoes. Participants in the control group will not be provided with the Orthotic and will run in the participants regular running shoes. All participants (in both groups) will be asked to provide data following each run and also once a week regarding any injury sustained in the preceding 7 days. The minimum required data set will comprise of the personal details and consent on initial enrolment, ongoing consent and data from at least 10 runs (there are 5 individual pieces of information from each run - the date of the run, the distance, the time taken, whether an Orthotic was used or not and the comfort during the run), and injury data every week during the 8 week study period.

Interventions

DEVICEAetrex L700 Speed orthotic

An orthotic insole to be inserted into running shoes. Features Aetrex Arch Support to help biomechanically align the body & help prevent common foot pain such as Plantar Fasciitis, Arch Pain, and Metatarsalgia. Helps prevent injury, alleviate discomfort and helps reduce fatigue while running

Sponsors

Aetrex Worldwide Inc
CollaboratorINDUSTRY
Talita Cumi Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Aged 18 years and over. * Used to running at least 5kms in the last 1 year.

Exclusion criteria

* Are currently using a prescription orthotic. * Have any ongoing pain or deformity in the foot. * Have been advised by a doctor to not exercise due to a serious health condition. * Have undergone any surgery in the last 6 months. * Have undergone any surgery on the foot during lifetime.

Design outcomes

Primary

MeasureTime frameDescription
Changes in levels of comfort as assessed by a Visual Analogue Scale (VAS)Up to 8 weeksParticipants will record Comfort on a self-report Visual analogue scale (VAS) of 0 to 10 scale where 0 is No comfort and 10 is Maximum comfort
Running Duration via a self report questionnaireUp to 8 weeksParticipants will record run duration in Hours:Minutes
Running Distance via a self report questionnaireUp to 8 weeksParticipants will record run distance in Kilometres/Miles.

Secondary

MeasureTime frameDescription
Running related InjuriesOnce a week during the 8-week trial period.Participants will report any running related injuries via a self-report questionnaire. A human model will be used to identify the area of pain. Further choices and information will be provided to the participant on common injuries to allow the identification of the injury. This is a binary measure to observe whether an injury was sustained or not.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026